FDA OK's Odomza from Novartis for common skin cancer type
Friday, July 24, 2015 - 14:20
in Health & Medicine
EAST RUTHERFORD, N.J. (AP) -- A new drug for advanced basal cell carcinoma, an increasingly common cancer in the skin's top layer, has won Food and Drug Administration approval....